Similar articles for PMID: 25182745

Year	Number of Results
1989	2
1991	2
1992	7
1993	6
1994	4
1996	3
1997	6
1998	5
1999	4
2000	11
2001	9
2002	7
2003	6
2004	7
2005	6
2006	17
2007	10
2008	19
2009	16
2010	19
2011	21
2012	23
2013	20
2014	21
2015	33
2016	38
2017	38
2018	32
2019	31
2020	33
2021	32
2022	21
2023	14
2024	0

1

I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.

Sieczkowski E, Milenkovic I, Venkataramani V, Giera R, Ströbel T, Höftberger R, Liberski PP, Auff E, Wirths O, Bayer TA, Kovacs GG. Sieczkowski E, et al. J Alzheimers Dis. 2015;44(1):103-14. doi: 10.3233/JAD-141524. J Alzheimers Dis. 2015. PMID: 25182745

2

Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.

Venkataramani V, Wirths O, Budka H, Härtig W, Kovacs GG, Bayer TA. Venkataramani V, et al. J Alzheimers Dis. 2012;29(2):361-71. doi: 10.3233/JAD-2011-111379. J Alzheimers Dis. 2012. PMID: 22232007 Free article.

3

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.

Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Clinton LK, et al. J Neurosci. 2010 May 26;30(21):7281-9. doi: 10.1523/JNEUROSCI.0490-10.2010. J Neurosci. 2010. PMID: 20505094 Free PMC article.

4

Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.

Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K. Fujishiro H, et al. Neurosci Lett. 2010 Dec 3;486(1):19-23. doi: 10.1016/j.neulet.2010.09.036. Epub 2010 Sep 17. Neurosci Lett. 2010. PMID: 20851165

5

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.

6

Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.

Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R, Lendon CL, Goate AM, McKeel DW Jr, Morris JC. Snider BJ, et al. Arch Neurol. 2005 Dec;62(12):1821-30. doi: 10.1001/archneur.62.12.1821. Arch Neurol. 2005. PMID: 16344340

7

The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ.

Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird TD, Nochlin D, Schellenberg GD, Brundin R, Olofsson T, Soliymani R, Baumann M, Wirths O, Bayer TA, Nilsson LN, Basun H, Lannfelt L, Ingelsson M. Kalimo H, et al. Acta Neuropathol Commun. 2013 Sep 10;1:60. doi: 10.1186/2051-5960-1-60. Acta Neuropathol Commun. 2013. PMID: 24252272 Free PMC article.

8

Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.

Sierra M, Gelpi E, Martí MJ, Compta Y. Sierra M, et al. Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62. doi: 10.1111/nan.12308. Epub 2016 Apr 1. Neuropathol Appl Neurobiol. 2016. PMID: 26810462

9

Lewy body pathology in Alzheimer's disease.

Kotzbauer PT, Trojanowsk JQ, Lee VM. Kotzbauer PT, et al. J Mol Neurosci. 2001 Oct;17(2):225-32. doi: 10.1385/jmn:17:2:225. J Mol Neurosci. 2001. PMID: 11816795 Review.

10

[Expression of proteins related neurodegeneration in autopsy brains of the aged].

Zhu M, Meng X, Wang L, Hu Y, Zhang H, Han Z. Zhu M, et al. Zhonghua Bing Li Xue Za Zhi. 2014 Oct;43(10):651-6. Zhonghua Bing Li Xue Za Zhi. 2014. PMID: 25567589 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

467 results

Results by year